Received: 27 March 2021
Accepted: 6 September 2021
First Online: 23 September 2021
: This study was approved by the Chang Gung Medical Foundation Institutional Review Board (IRB No.: 104-1961C, 104-2308B, 201800433B0D001, and 201901274B0D001). This study was carried out according to the Declaration of Helsinki. Prior to enrollment, all patients or their legal proxies will be given detailed information about the aims, scope, and possible consequences of the trial by a physician. Written informed consent was obtained from all study participants or their legal proxies.
: Not applicable.
: The authors declare that they have no competing interests.